Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 17


Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.

Kowalska JD, Kubicka J, Siwak E, Pulik P, Firląg-Burkacka E, Horban A; Polish Observational Cohort of HIV/AIDS Patients (POLCA) Study Group.

AIDS Res Ther. 2016 Jan 7;13:2. doi: 10.1186/s12981-015-0084-5. eCollection 2016.


The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons.

Pietraszkiewicz E, Firlag-Burkacka E, Horban A, Kowalska JD.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19733. doi: 10.7448/IAS.17.4.19733. eCollection 2014.


Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143.

Berenguer J, Wit F, Jansson PO, Schwimmer C, Kowalska JD, Saillard J, Diallo A, Pozniak AL, Raffi F, Grarup J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19572. doi: 10.7448/IAS.17.4.19572. eCollection 2014.


Factors responsible for incomplete linkage to care after HIV diagnosis: preliminary results from the Test and Keep in Care (TAK) project.

Ankiersztejn-Bartczak M, Firląg-Burkacka E, Czeszko-Paprocka H, Kubicka J, Cybula A, Horban A, Kowalska JD.

HIV Med. 2015 Feb;16(2):88-94. doi: 10.1111/hiv.12175. Epub 2014 Aug 15.


Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group.

Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8.


The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.

Mocroft A, Bannister WP, Kirk O, Kowalska JD, Reiss P, D'Arminio-Monforte A, Gatell J, Fisher M, Trocha H, Rakhmanova A, Lundgren JD; EuroSIDA Study in EuroCOORD.

Antivir Ther. 2012;17(7):1291-300. doi: 10.3851/IMP2407. Epub 2012 Sep 26.


System to classify cause of deaths in HIV-positive persons: time to harmonize.

Kowalska JD, Smith C, Lundgren JD.

AIDS. 2012 Sep 10;26(14):1835-6. doi: 10.1097/QAD.0b013e3283577427. No abstract available.


Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.

Reekie J, Kowalska JD, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A, Horban A, Kirk O, Lundgren JD, Mocroft A; EuroSIDA in EuroCoord.

PLoS One. 2012;7(7):e41673. doi: 10.1371/journal.pone.0041673. Epub 2012 Jul 23.


Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.

Kowalska JD, Reekie J, Mocroft A, Reiss P, Ledergerber B, Gatell J, d'Arminio Monforte A, Phillips A, Lundgren JD, Kirk O; EuroSIDA study group.

AIDS. 2012 Jan 28;26(3):315-23. doi: 10.1097/QAD.0b013e32834e8805.


Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata.

Reekie J, Gatell JM, Yust I, Bakowska E, Rakhmanova A, Losso M, Krasnov M, Francioli P, Kowalska JD, Mocroft A; EuroSIDA in EuroCoord.

AIDS. 2011 Nov 28;25(18):2259-68. doi: 10.1097/QAD.0b013e32834cdb4b.


The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology.

Kowalska JD, Friis-Møller N, Kirk O, Bannister W, Mocroft A, Sabin C, Reiss P, Gill J, Lewden C, Phillips A, D'Arminio Monforte A, Law M, Sterne J, De Wit S, Lundgren JD; CoDe Working Group; D:A:D Study Group.

Epidemiology. 2011 Jul;22(4):516-23. doi: 10.1097/EDE.0b013e31821b5332.


A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.

Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, Begovac J, Sambatakou H, Pedersen C, Lundgren JD, Kirk O; Eurosida Study Group.

HIV Clin Trials. 2011 Mar-Apr;12(2):109-17. doi: 10.1310/hct1202-109.


Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.

Neuhaus J, Angus B, Kowalska JD, La Rosa A, Sampson J, Wentworth D, Mocroft A; INSIGHT SMART and ESPRIT study groups.

AIDS. 2010 Mar 13;24(5):697-706. doi: 10.1097/QAD.0b013e3283365356.


Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.

Kowalska JD, Kirk O, Mocroft A, Høj L, Friis-Møller N, Reiss P, Weller I, Lundgren JD.

HIV Med. 2010 Mar;11(3):200-8. doi: 10.1111/j.1468-1293.2009.00763.x. Epub 2009 Oct 27.


Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.

Kowalska JD, Mocroft A, Blaxhult A, Colebunders R, van Lunzen J, Podlekareva D, Hansen AB, Machala L, Yust I, Benfield T; EuroSIDA Study Group.

AIDS Res Hum Retroviruses. 2007 Oct;23(10):1183-8.


[Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].

Kowalska JD, Firlag-Burkacka E, Niezabitowska M, Bakowska E, Ignatowska A, Pulik P, Horban A.

Przegl Epidemiol. 2006;60(4):789-94. Polish.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk